Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse

Meletios Dimopoulos; Katja Weisel; Philippe Moreau; Larry D. Anderson; Darrell White; Jesus San-Miguel; Pieter Sonneveld; Monika Engelhardt; Matthew Jenner; Alessandro Corso; Jan Dürig; Michel Pavic; Morten Salomo; Eva Casal; Shankar Srinivasan; Xin Yu; Tuong Vi Nguyen; Tsvetan Biyukov; Teresa Peluso; Paul Richardson

doi:10.1038/s41375-020-01021-3

Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse

Meletios Dimopoulos, Katja Weisel, Philippe Moreau, Larry D. Anderson, Darrell White, Jesus San-Miguel, Pieter Sonneveld, Monika Engelhardt, Matthew Jenner, Alessandro Corso, Jan Dürig, Michel Pavic, Morten Salomo, Eva Casal, Shankar Srinivasan, Xin Yu, Tuong Vi Nguyen, Tsvetan Biyukov, Teresa Peluso, Paul Richardson

Research output: Contribution to journal › Article › peer-review

42 Citations (Scopus)

Original language	English
Pages (from-to)	1722-1731
Number of pages	10
Journal	Leukemia
Volume	35
Issue number	6
DOIs	https://doi.org/10.1038/s41375-020-01021-3
Publication status	Published - Jun 2021
Externally published	Yes

ASJC Scopus Subject Areas

Hematology
Oncology
Cancer Research

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/s41375-020-01021-3

Cite this

Dimopoulos, M., Weisel, K., Moreau, P., Anderson, L. D., White, D., San-Miguel, J., Sonneveld, P., Engelhardt, M., Jenner, M., Corso, A., Dürig, J., Pavic, M., Salomo, M., Casal, E., Srinivasan, S., Yu, X., Nguyen, T. V., Biyukov, T., Peluso, T., & Richardson, P. (2021). Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse. Leukemia, 35(6), 1722-1731. https://doi.org/10.1038/s41375-020-01021-3

Dimopoulos, M, Weisel, K, Moreau, P, Anderson, LD, White, D, San-Miguel, J, Sonneveld, P, Engelhardt, M, Jenner, M, Corso, A, Dürig, J, Pavic, M, Salomo, M, Casal, E, Srinivasan, S, Yu, X, Nguyen, TV, Biyukov, T, Peluso, T & Richardson, P 2021, 'Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse', Leukemia, vol. 35, no. 6, pp. 1722-1731. https://doi.org/10.1038/s41375-020-01021-3

@article{3303ceaa6abd48b49513b3a5ae8b3cc0,

title = "Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse",

author = "Meletios Dimopoulos and Katja Weisel and Philippe Moreau and Anderson, {Larry D.} and Darrell White and Jesus San-Miguel and Pieter Sonneveld and Monika Engelhardt and Matthew Jenner and Alessandro Corso and Jan D{\"u}rig and Michel Pavic and Morten Salomo and Eva Casal and Shankar Srinivasan and Xin Yu and Nguyen, {Tuong Vi} and Tsvetan Biyukov and Teresa Peluso and Paul Richardson",

note = "Publisher Copyright: {\textcopyright} 2020, The Author(s).",

year = "2021",

month = jun,

doi = "10.1038/s41375-020-01021-3",

language = "English",

volume = "35",

pages = "1722--1731",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "6",

}

TY - JOUR

T1 - Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM)

T2 - outcomes by prior treatment at first relapse

AU - Dimopoulos, Meletios

AU - Weisel, Katja

AU - Moreau, Philippe

AU - Anderson, Larry D.

AU - White, Darrell

AU - San-Miguel, Jesus

AU - Sonneveld, Pieter

AU - Engelhardt, Monika

AU - Jenner, Matthew

AU - Corso, Alessandro

AU - Dürig, Jan

AU - Pavic, Michel

AU - Salomo, Morten

AU - Casal, Eva

AU - Srinivasan, Shankar

AU - Yu, Xin

AU - Nguyen, Tuong Vi

AU - Biyukov, Tsvetan

AU - Peluso, Teresa

AU - Richardson, Paul

PY - 2021/6

Y1 - 2021/6

UR - http://www.scopus.com/inward/record.url?scp=85090306164&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85090306164&partnerID=8YFLogxK

U2 - 10.1038/s41375-020-01021-3

DO - 10.1038/s41375-020-01021-3

M3 - Article

C2 - 32895455

AN - SCOPUS:85090306164

SN - 0887-6924

VL - 35

SP - 1722

EP - 1731

JO - Leukemia

JF - Leukemia

IS - 6

ER -

Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse

ASJC Scopus Subject Areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this